An observational study in Anal Fistula Surgery, Anal Fistula and Perianal Fistula, sponsored by National and Kapodistrian University of Athens. Recruiting at 1 site in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by National and Kapodistrian University of Athens · Observational
Perianal fistulas are a chronic anorectal condition associated with significant morbidity, including pain, persistent discharge, infection, and impaired continence, all of which can substantially affect patients' quality of life. Surgical management aims to eradicate the fistulous tract while preserving anal sphincter function and continence.
Despite numerous available surgical techniques, high-quality comparative evidence regarding optimal management remains limited. This prospective observational study aims to evaluate clinical outcomes, functional outcomes, and patient-reported quality of life following surgical treatment of perianal fistulas.
The study will collect both clinician-reported and patient-reported outcomes over a 12-month follow-up period. Outcomes of interest include fistula healing, recurrence, postoperative complications, continence status, symptom burden, and health-related quality of life. The findings are expected to provide real-world data that may inform clinical decision-making and contribute to improved patient-centered care.
Background
Perianal fistulas are abnormal tracts that connect the anal canal or rectum to the perianal skin, most often developing after a perianal abscess that originates near the anal glands at the dentate line. The majority of fistulas arise secondary to an abscess. Treatment aims to eradicate the tract, prevent recurrence, and preserve continence by protecting the sphincter mechanism. Fistulas are classified anatomically (Parks) and, more clinically, as simple (low) or complex. Simple fistulas involve only the distal third of the external sphincter and are usually cured with sphincter-dividing procedures such as fistulotomy or fistulectomy, which have high healing rates and low continence risk. Complex fistulas-those that affect a larger portion of the sphincter, have multiple tracts, or are recurrent-require sphincter-preserving techniques (e.g., mucosal advancement flap, LIFT, laser treatment, plugs, or setons), although these approaches often carry higher recurrence rates. Current guidelines are hampered by limited high-quality evidence and marked heterogeneity in outcome definitions, measurement tools, and reporting practices, highlighting the need for standardized prospective data.
Study Objective and Design
The primary aim is to generate high-quality, real-world observational data on surgical management of perianal fistulas. The study will conduct a prospective cohort enrolling adult participants at the time of definitive fistula surgery and will follow them for 12 months. The cohort will be stratified by fistula complexity (simple vs. complex) and by surgical strategy (partially sphincter-dividing versus sphincter-preserving). The study will capture demographic, clinical, imaging, and operative information to explore how these variables relate to healing, recurrence, continence preservation, and patient-reported quality of life.
Data Collection and Analysis
Baseline data will include age, sex, comorbidities, pre-operative imaging, and any preceding seton placement or previous surgery. Operative details-type of technique, extent of sphincter involvement, intra-operative findings-will be recorded in a standardized case-report form. Follow-up assessments will occur at 1, 3, 6, and 12 months post-operatively and will collect clinician-reported endpoints (clinical and radiological healing, recurrence, complications graded by Clavien-Dindo) and patient-reported outcomes (continence status, symptom burden, health-related quality of life, psychological impact, and satisfaction) using validated instruments. Descriptive statistics will summarize patient and treatment characteristics; multivariable logistic and Cox regression models will evaluate associations between surgical approach, imaging findings, and outcomes, adjusting for confounders such as age, comorbidity, and fistula complexity. Subgroup analyses will compare outcomes across the two surgical strategy groups.
Anticipated Impact
By employing uniform outcome definitions and integrating both clinician- and patient-centered metrics, the study will fill a critical evidence gap regarding the comparative effectiveness of current fistula surgeries. The findings are expected to clarify which techniques achieve optimal healing while minimizing continence loss and to provide robust data that can refine clinical guidelines, inform shared-decision making, and ultimately improve functional and quality-of-life outcomes for patients with perianal fistulas.
The study will enroll adult patients with cryptoglandular perianal fistulas who are scheduled for elective surgical repair. Participants will be free of inflammatory bowel disease and major anorectal resections, and they will be able to provide informed consent, complete validated patient-reported outcome measures, and comply with the scheduled 12-month follow-up protocol.
Exclusion Criteria:
Adults (≥ 18 y) undergoing any elective surgical repair for a primary or recurrent perianal fistula (simple or complex) in our center. All participants are followed prospectively for a minimum of 12 months with standardized clinician- and patient-reported outcome assessments.
Procedure: Perianal fistula surgical repair
Patients undergo the operative procedure that their treating colorectal surgeon selects as routine clinical care for a primary or recurrent perianal fistula. The operative approach may be a sphincter-dividing technique (e.g., fistulotomy or fistulectomy) or a sphincter-preserving technique (e.g., ligation of the intersphincteric fistula tract \[LIFT\], mucosal advancement flap, laser fistula treatment, fistula plug, autologous biologic product injection, or seton placement). No investigational devices or experimental protocols are used; the study records the specific technique, intra-operative details, and any adjunctive measures (draining seton, pre-operative imaging, antibiotics, etc.) to allow comparison of real-world outcomes across all accepted surgical modalities for perianal fistulas.
Proportion of patients with complete fistula healing (clinical examination)
No clinically detectable perianal discharge, no signs of infection or inflammation, and no palpable/visible fistulous tract on physical examination.
Time frame: 1, 3, 6, 12 and 24 months
Quality of Life (QoL)
Anal Fistula Quality of Life (AF-QoL) questionnaire (0 = worst QoL, 100 = best QoL; higher scores indicate better health-related QoL)
Time frame: 1, 3, 6, 12 and 24 months
Recurrence rate
Re-appearance of any fistulous tract (clinical or imaging confirmation) after a documented period of ≥ 6months of complete healing, or identification of a new, distinct fistulous tract that was not present at baseline
Time frame: 12 and 24 months
Incontinence symptoms
Vaizey / St Mark's Incontinence Score (0 = perfect continence, 24 = complete incontinence)
Time frame: 1, 3, 6, 12 and 24 months
Complications, Re-interventions, Readmission, Mortality
Any adverse events (yes/no). Includes surgical site infection, wound dehiscence, bleeding, urinary retention. Any need for radiological or surgical re-intervention (yes/no), unplanned readmission (yes/no), or mortality (yes/no).
Time frame: 1, 3, 6, 12 and 24 months
Clavien-Dindo classification of complications
Complication, graded by Clavien-Dindo classification (I-V)
Time frame: 1, 3, 6, 12 and 24 months
Patient satisfaction
Numerical Rating Scale (NRS: 0-10; 0 indicating no pain, 10 worse pain)
Time frame: 1, 3, 6, 12 and 24 months
EQ-5D-5L
Quality of Life descriptive system comprising of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels (0: no problems, 5: severe problems)
Time frame: 1, 3, 6, 12 and 24 months
EQ VAS
The EQ VAS records the patient's self-rated health on a vertical visual analogue scale (0: worse health you can imagine and 100: best health you can imagine)
Time frame: 1, 3, 6, 12 and 24 months
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National and Kapodistrian University of Athens